Sep 12, 2023 / 06:15PM GMT
Terence C. Flynn - Morgan Stanley, Research Division - Equity Analyst
Great. Well, thanks for joining us, everybody. I'm Terence Flynn, the U.S. biopharma analyst here at Morgan Stanley and I'm very pleased to be hosting Arvinas this afternoon.
Before we get started, I have to make some disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Joining us today from the company, we have Ron Peck, who's the company's Chief Medical Officer; and Randy Teel, who is Head of Corporate Strategy and Business Development. Thanks so much both for joining me. Really appreciate you taking time out of your day to spend it with us today.
Questions and Answers:
Terence C. Flynn - Morgan Stanley, Research Division - Equity AnalystMaybe I thought we'd start with just a quick overview, kind of the platform but also the
Trustpilot
